Skip to content
SerpHike
Get Free Proposal
Industry Playbook · Pharma

Digital Marketing for Pharma: Compliant Within the Magic Remedies Act

For pharmaceutical companies in India and abroad that sell to doctors, distributors and export buyers rather than the public. Marketing planned around the Drugs and Magic Remedies Act, measured on qualified RFQs and HCP enquiries, not consumer reach.

Pharma digital marketing means reaching healthcare professionals, distributors and export buyers within the rules on drug advertising, plus unbranded disease awareness where the law allows it. It suits formulation, generics and API companies that grow through trade enquiries. You get searchable molecule and portfolio pages, RFQ funnels, HCP content and a medical review step written into every timeline.

Need enquiries your regulatory team will approve?Get Your Free Growth Proposal
Hub for pharma marketing placing the Magic Remedies Act at the centre of HCP, distributor, education and consumer content
The Magic Remedies Act shapes pharma content, so each audience gets only what is permitted.

Why pharma marketing cannot borrow the consumer playbook

If you market a pharmaceutical company, most of the tactics other sectors lean on are closed to you. In India, the Drugs and Magic Remedies (Objectionable Advertisements) Act restricts advertising claims for treating a long list of conditions, and promotion to doctors falls under the Uniform Code for Pharmaceutical Marketing Practices.

So the agency pitch built on Instagram reach and consumer ads is one your regulatory team will reject, and rightly. The real fear is hiring someone who either breaks the rules or produces content that sits in medical review for months.

Digital marketing in the pharma industry: three audiences

Digital marketing in the pharmaceutical industry differs from most sectors because what you can say depends on who is reading. Most pharma companies market to three audiences, each with its own content and its own limits.

AudienceWhat they look forWhat we build
Healthcare professionalsClinical evidence, dosing information, educationHCP resources behind appropriate access controls
Distributors and trade buyersPortfolio, certifications, regulatory approvalsProduct and molecule pages with RFQ forms, found through generic-name searches
Patients and the publicPlain information about a conditionUnbranded disease awareness where the law permits it, reviewed by your medical and regulatory teams

Which pharma companies this suits, and which it does not

This suits formulation companies, generics and API manufacturers, and exporters whose growth depends on distributors, institutions and overseas buyers finding them and asking for a quote. It also suits companies planning disease awareness work that already have reviewers who can sign content off.

It does not suit a brand that wants prescription medicines promoted to the public, or a team that expects content to go live without medical review. Pharma is not a sector we list as past client work. We have worked with private hospitals and medical clinics, where clinical sign-off before publishing is routine, and our healthcare digital marketing work follows the same discipline.

What the pharma work includes

  • Molecule and generic-name search: product and molecule-information pages built for the searches buyers and pharmacists run, by molecule, formulation and generic name.
  • Distributor and export funnels: portfolio pages showing your certifications and regulatory approvals, ending in an RFQ form tracked as a conversion.
  • HCP content: clinical evidence summaries, dosing information and educational resources behind appropriate access controls.
  • Disease awareness: unbranded patient education, only where the market permits it, drafted for your medical and regulatory teams to review.
  • Corporate reputation on LinkedIn: manufacturing quality, research and talent content that also supports hiring.

Lead generation, content and SEO carry most of the load. For API and generics companies the work sits close to B2B manufacturing and export marketing: specifications, regulatory filings and RFQ journeys.

How an engagement runs, with medical review built in

It starts with a free 30-minute call. We ask which markets you sell into, who your buyers are and who signs off content, because that sign-off chain sets the pace. The free audit follows in 3 to 5 business days, covering your site, rankings and the competitors your buyers compare you with.

A five-step flow: a free call that maps who signs off content, a free audit in 3 to 5 business days, a 90-day plan with medical review dates, a named specialist building within the rules, and a monthly report on RFQs and qualified enquiries.
Medical and regulatory review dates sit inside the plan from the first week.

If you go ahead, you get a 90-day plan at a fixed monthly price, with medical and regulatory review dates written into it so review never becomes the bottleneck. A named senior specialist runs the account end to end, and each month you get one plain report on RFQs and qualified enquiries, with rankings and traffic as context.

What we would check first, in place of a pharma case study

We do not have a published pharma case study, and we will not borrow a result from another sector to fill the gap; our case studies are education and ecommerce brands.

On a pharma site, the free audit starts with three questions. Are your molecule and product pages indexed and found by generic name? Is every RFQ, sample request and tender enquiry tracked, so trade buyers can be told apart from job seekers and consumers? Do your portfolio pages show the approvals a distributor checks before replying?

Working with us from India or from abroad

For pharma companies in India, we work over WhatsApp and phone calls in IST, and you are welcome to meet the team at our office in Mansa, Punjab. Doctor-facing campaigns are planned around the Uniform Code, and anything public-facing around the Drugs and Magic Remedies Act.

If you are outside India, or an Indian exporter selling into regulated markets, we keep a working slot inside your business hours. Contracts roll monthly and every account stays in your name. UK content assumes prescription-only medicines are not advertised to the public there. In markets such as the US and Canada, our fees are often 30 to 60% lower than a comparable local agency because overheads in India are lower.

FAQ

Can prescription drugs be advertised directly to consumers in India?
Not freely. The Drugs and Magic Remedies Act restricts advertising claims for a long list of conditions, so the marketing focuses on doctors, distributors and unbranded education where the rules permit it.
Can a pharma company use social media?
Yes, for corporate news, recruitment, disease awareness and HCP education where the rules allow. Product promotion to the public is restricted in most markets, so product content stays off public feeds.
How is marketing an API or generics manufacturer different?
It is closer to B2B manufacturing. Buyers want specifications, certifications and regulatory filings, and the journey ends in an RFQ rather than a sale.
How do you measure success for a pharma company?
Against qualified HCP engagement, distributor and export RFQs, sample requests and tender invitations. Consumer sales are not the measure.
Will medical review slow the work down?
Every piece of pharma content needs medical and regulatory review before publication. Because the review dates are in the 90-day plan, drafts reach your reviewers on a schedule rather than in a rush.
Published Aug 4, 2026 · Last updated Nov 14, 2026

Ready for compliant pharma marketing?

info@serphike.com +91 70096 23687Serving clients across India, the UK, UAE, Singapore, Canada, the US and Australia
Get a free growth proposal
We reply within one business day.
No contract, no spam. See our Privacy Policy.